IGC Pharma, Inc. (IGC)
NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.3490 |
| Open | 0.3650 |
| Bid | 0.3311 x 900 |
| Ask | 0.3590 x 800 |
| Day's range | 0.3318 - 0.3650 |
| 52-week range | 0.2800 - 0.5200 |
| Volume | |
| Avg. volume | 241,877 |
| Market cap | 19.372M |
| Beta (5Y monthly) | 2.96 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2200 |
| Earnings date | 30 Oct 2023 - 03 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireIGC Announces Results of its 2023 Annual Stockholders Meeting
POTOMAC, Md., August 21, 2023--IGC Announces Results of its 2023 Annual Stockholders Meeting
Business WireIGC Pharma Reports First Quarter Results; Company Continues to Make Significant Progress Advancing Its Lead Alzheimer’s Candidate Through Phase 2 Clinical Trials
POTOMAC, Md., August 14, 2023--IGC Pharma Reports First Quarter Results; Company Continues to Make Significant Progress Advancing Its Lead Alzheimer’s Candidate.
Business WireIGC Pharma Expands Phase 2 Trial of IGC-AD1 to Include the University of Puerto Rico
POTOMAC, Md., August 02, 2023--IGC Pharma Expands Phase 2 Trial of IGC-AD1 to Include the University of Puerto Rico
© 2023 Yahoo. All rights reserved.
